CD98 is a promising prognostic biomarker in biliary tract cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 6, 2014, Pages 654-657

  Kaira, Kyoichi ^a   Sunose, Yutaka ^a   Oriuchi, Noboru ^a   Kanai, Yoshikatsu ^b   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

amino acid transporter; biliary tract cancer; CD98; prognostic factor

Indexed keywords

AMINO ACID TRANSPORTER; BIOLOGICAL MARKER; CD34 ANTIGEN; CD98 ANTIGEN; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CORRELATIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; BILE DUCT NEOPLASMS; CARCINOMA; CHEMISTRY; CHOLANGIOCARCINOMA; DISEASE FREE SURVIVAL; GALLBLADDER NEOPLASMS; HEPATIC DUCT; INTRAHEPATIC BILE DUCT; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, CD98; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; BIOMARKERS, TUMOR; CARCINOMA; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; KI-67 ANTIGEN; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 84941883972     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60278-2     Document Type: Article

References (8)

1. K Kaira, Y Sunose, Y Ohshima, NS Ishioka, K Arakawa, T Ogawa et al. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer BMC Cancer 13 2013 482
2. Y Kanai, H Segawa, Ki Miyamoto, H Uchino, E Takeda, H Endou Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) J Biol Chem 273 1998 23629 23632
3. K Kaira, Y Sunose, K Arakawa, T Ogawa, N Sunaga, K Shimizu et al. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer Br J Cancer 107 2012 632 638
4. JM Cantor, MH Ginsberg CD98 at the crossroads of adaptive immunity and cancer J Cell Sci 125 2012 1373 1382
5. K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga et al. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases Ann Surg Oncol 16 2009 3473 3481
6. K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga et al. L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms Cancer Sci 99 2008 2380 2386
7. HT Nguyen, G Dalmasso, L Torkvist, J Halfvarson, Y Yan, H Laroui et al. CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice J Clin Invest 121 2011 1733 1747
8. H Ohkame, H Masuda, Y Ishii, Y Kanai Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models J Surg Oncol 78 2001 265 272